Compound name
Ripasudil
Compound Image
Ripasudil.png
SMILES
CC1CNCCCN1S(=O)(=O)C2=CC=CC3=CN=CC(=C32)F
MW
323.40
Brutto
C15H18FN3O2S
InChI
InChI=1S/C15H18FN3O2S/c1-11-8-17-6-3-7-19(11)22(20,21)14-5-2-4-12-9-18-10-13(16)15(12)14/h2,4-5,9-11,17H,3,6-8H2,1H3/t11-/m0/s1
InChI Key
QSKQVZWVLOIIEV-NSHDSACASA-N
Approval Jurisdiction
2014 Japan
Approved for clinical use
Glaucoma Ocular Hypertension
CAS
223645-67-8
PubChem CID
9863672
Action
ROCK1/2
Approved Drug List
1
Commercial Vendor
Kowa Company
Reference
Reference 2